<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="51865">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01786330</url>
  </required_header>
  <id_info>
    <org_study_id>220121565</org_study_id>
    <secondary_id>12-049</secondary_id>
    <nct_id>NCT01786330</nct_id>
  </id_info>
  <brief_title>Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?</brief_title>
  <official_title>Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zachary Kuhlmann, DO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study investigating the use of abdominal binders after cesarean sections.
      The researchers are testing whether elastic abdominal binders improve postoperative pain
      control and reduce postoperative blood loss. Blood loss and pain control are both concerns
      after giving birth. It is hoped that the use of an abdominal binder after giving birth will
      provide a non-pharmacologic way to to reduce blood loss and manage pain.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Hemoglobin concentration</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Hemoglobin concentration will be assessed 24 hours after surgery by assessing routine post-operative lab values.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF-MPQ2 Score</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain assessment scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receives elastic abdominal binders after surgery. Binder used is Procare manufactured by DJO, LLC. Binders are to be worn for 24 hours after surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receives standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Procare abdominal binder</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cesarean section at term (at least 39 weeks gestation) scheduled in advance

          -  Singleton gestation confirmed by ultrasound in the current pregnancy

          -  Body mass index 20-40 kg/m2 (at first prenatal visit or pre-pregnancy)

          -  None of these pregnancy complications in the current pregnancy:

               1. bleeding disorder or use of anticoagulants other than low-dose heparin

               2. abnormal placenta (placenta previa or accrete)

               3. Preoperative hemoglobin less than 10 mg/dL

               4. Chorioamnionitis (intrauterine infection)

          -  No chronic pain syndrome (defined as participating in formal chronic pain management
             within the past year)

          -  Able to read English and understand spoken English

        Exclusion Criteria:

          -  Onset of labor prior to time when the cesarean was scheduled

          -  Complications during performance of cesarean or discovered during cesarean:

               1. placenta accreta, increta, or percreta

               2. vasa previa

               3. cesarean hysterectomy required for severe hemorrhage

               4. organ damage during cesarean (cystotomy, enterotomy, ureteral injury)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zachary Kuhlmann, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liesa Hopper</last_name>
    <phone>316-293-1880</phone>
    <email>lhopper@kumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kansas School of Medicine-Wichita</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liesa Hopper</last_name>
      <phone>316-293-1880</phone>
      <email>lhopper@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Zachary Kuhlmann, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jamie H Gustafson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Linda Frazier, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wesley Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liesa Hopper</last_name>
      <phone>316-293-1880</phone>
      <email>lhopper@kumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 5, 2013</lastchanged_date>
  <firstreceived_date>February 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kansas Medical Center Research Institute</investigator_affiliation>
    <investigator_full_name>Zachary Kuhlmann, DO</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
